Ubs Group Ag Jasper Therapeutics, Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.46 - $8.9 $12,647 - $244,705	27,495 Added 14.62%	215,521 $103,000
Q3 2022 Nov 10, 2022	BUY	$0.08 - $22.6 $14,598 - $4.12 Million	182,487 Added 3294.58%	188,026 $148,000
Q2 2022 Aug 10, 2022	BUY	$1.73 - $3.86 $9,582 - $21,380	5,539 New	5,539 $11,000
Q1 2022 May 16, 2022	SELL	$2.96 - $8.01 $7,553 - $20,441	-2,552 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.21 - $16.42 $14,513 - $33,053	2,013 Added 373.47%	2,552 $20,000
Q3 2021 Nov 15, 2021	BUY	$9.22 - $15.12 $4,969 - $8,149	539 New	539 $6,000

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $257M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.